Antistaphylococcal Activity of LBM415, a New Peptide Deformylase Inhibitor, Compared with Those of Other Agents

The MICs of LBM415, a new peptide diformylase inhibitor, were ≤0.06 to 4.0 μg/ml for 258 isolates of Staphylococcus aureus and coagulase-negative staphylococci. LBM415 MICs were similar irrespective of whether the strains were methicillin susceptible or resistant. All strains were also susceptible t...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Credito, Kim, Lin, Gengrong, Ednie, Lois M., Appelbaum, Peter C.
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 2004
Assuntos:	Susceptibility
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC521910/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15388473/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.48.10.4033-4036.2004
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!